PT69172B - Processo para a preparacao de 6-n-propil-8-metoximetil- ou -metilmercaptometilee compostos afins - Google Patents

Processo para a preparacao de 6-n-propil-8-metoximetil- ou -metilmercaptometilee compostos afins

Info

Publication number
PT69172B
PT69172B PT69172A PT6917279A PT69172B PT 69172 B PT69172 B PT 69172B PT 69172 A PT69172 A PT 69172A PT 6917279 A PT6917279 A PT 6917279A PT 69172 B PT69172 B PT 69172B
Authority
PT
Portugal
Prior art keywords
metilmercaptometilee
methoxymethyl
propyl
compounds
preparation
Prior art date
Application number
PT69172A
Other languages
English (en)
Other versions
PT69172A (en
Inventor
Edmund Carl Kornfeld
Nicholas James Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT69172A publication Critical patent/PT69172A/pt
Publication of PT69172B publication Critical patent/PT69172B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
PT69172A 1978-02-08 1979-02-02 Processo para a preparacao de 6-n-propil-8-metoximetil- ou -metilmercaptometilee compostos afins PT69172B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (2)

Publication Number Publication Date
PT69172A PT69172A (en) 1979-03-01
PT69172B true PT69172B (pt) 1992-05-29

Family

ID=25366703

Family Applications (1)

Application Number Title Priority Date Filing Date
PT69172A PT69172B (pt) 1978-02-08 1979-02-02 Processo para a preparacao de 6-n-propil-8-metoximetil- ou -metilmercaptometilee compostos afins

Country Status (36)

Country Link
US (1) US4166182A (pt)
EP (1) EP0003667B1 (pt)
JP (1) JPS54115400A (pt)
AR (1) AR228341A1 (pt)
AT (1) AT371817B (pt)
AU (1) AU523172B2 (pt)
BE (1) BE873883A (pt)
BG (1) BG30474A3 (pt)
CA (1) CA1114368A (pt)
CH (1) CH639088A5 (pt)
CS (1) CS203951B2 (pt)
DD (1) DD141928A5 (pt)
DE (2) DE19375112I2 (pt)
DK (1) DK147362C (pt)
EG (1) EG14076A (pt)
ES (1) ES477547A1 (pt)
FI (1) FI65777C (pt)
FR (1) FR2416891A1 (pt)
GB (1) GB2014140B (pt)
GR (1) GR72776B (pt)
HU (1) HU179970B (pt)
IE (1) IE47827B1 (pt)
IL (1) IL56581A (pt)
LU (2) LU80886A1 (pt)
MX (2) MX5995E (pt)
MY (1) MY8500597A (pt)
NL (1) NL930106I2 (pt)
NZ (1) NZ189561A (pt)
PH (1) PH14903A (pt)
PL (3) PL120849B1 (pt)
PT (1) PT69172B (pt)
RO (3) RO81857A (pt)
SU (1) SU912045A3 (pt)
UA (1) UA6082A1 (pt)
YU (1) YU28279A (pt)
ZA (1) ZA79453B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
DE3868866D1 (de) * 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
US5272141A (en) * 1990-09-28 1993-12-21 Franco Fraschini Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) * 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ES2483722T3 (es) * 2001-06-08 2014-08-07 Ipsen Pharma Análogos quiméricos de somatostatina-dopamina
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
EP1485382B1 (en) * 2002-03-15 2008-11-19 Antibioticos S.p.A. Process for the synthesis of pergolide
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (en) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
US9777039B2 (en) 2012-11-01 2017-10-03 Ipsen Pharma S.A.S. Somatostatin analogs and dimers thereof
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
US4166182A (en) 1979-08-28
DE19375112I2 (de) 2003-06-12
IL56581A0 (en) 1979-05-31
AR228341A1 (es) 1983-02-28
CA1114368A (en) 1981-12-15
JPS54115400A (en) 1979-09-07
GR72776B (pt) 1983-12-05
HU179970B (en) 1983-01-28
MX9203107A (es) 1992-07-31
MX5995E (es) 1984-09-18
NZ189561A (en) 1981-12-15
ZA79453B (en) 1980-09-24
SU912045A3 (ru) 1982-03-07
DD141928A5 (de) 1980-05-28
IL56581A (en) 1982-05-31
RO81857B (ro) 1983-05-30
FI790351A (fi) 1979-08-09
PL120849B1 (en) 1982-03-31
LU88294I2 (fr) 1994-05-04
ES477547A1 (es) 1980-04-16
DK147362C (da) 1988-06-27
NL930106I1 (nl) 1993-10-18
PL213283A1 (pt) 1980-02-25
UA6082A1 (uk) 1994-12-29
IE790232L (en) 1979-08-08
AU4391779A (en) 1979-08-16
MY8500597A (en) 1985-12-31
PL126313B1 (en) 1983-07-30
GB2014140A (en) 1979-08-22
FI65777B (fi) 1984-03-30
RO81857A (ro) 1983-06-01
LU80886A1 (fr) 1979-06-07
JPS6363544B2 (pt) 1988-12-07
CH639088A5 (fr) 1983-10-31
RO81856A (ro) 1983-06-01
EP0003667A1 (en) 1979-08-22
EG14076A (en) 1983-12-31
DK147362B (da) 1984-07-02
PT69172A (en) 1979-03-01
BG30474A3 (en) 1981-06-15
NL930106I2 (nl) 1997-02-03
EP0003667B1 (en) 1982-07-14
DK51379A (da) 1979-09-18
BE873883A (fr) 1979-08-02
GB2014140B (en) 1982-08-04
ATA91479A (de) 1982-12-15
FI65777C (fi) 1984-07-10
DE2963320D1 (en) 1982-09-02
FR2416891B1 (pt) 1981-10-16
AT371817B (de) 1983-08-10
IE47827B1 (en) 1984-06-27
PL124704B1 (en) 1983-02-28
FR2416891A1 (fr) 1979-09-07
AU523172B2 (en) 1982-07-15
PH14903A (en) 1982-01-29
RO76889A (ro) 1981-08-30
RO81856B (ro) 1983-05-30
CS203951B2 (en) 1981-03-31
YU28279A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
PT69172B (pt) Processo para a preparacao de 6-n-propil-8-metoximetil- ou -metilmercaptometilee compostos afins
BR7906368A (pt) Processo para a preparacao de furanil-benzazois
BR7906947A (pt) Processo para a preparacao de n-fosfono-metil-glicina
BR8005018A (pt) Processo para a preparacao de 7-hidroxicumaranas
BR7905476A (pt) Processo para a preparacao de 4-fluor-3-fenoxi-tolueno
BR7901799A (pt) Processo para a preparacao de um composto de 4-halometilpiridina
BR8006948A (pt) Processo para a preparacao de 3-fenoxi-benzaldeidos
BR8004316A (pt) Processo para a preparacao de aldeidos
BR7905619A (pt) Processo para a preparacao de alquiltiometilfenois ou ariltiometilfenois
BR7904731A (pt) Processo para a preparacao de aldeidos
BR7900568A (pt) Processo para a preparacao de compostos contendo uniao de fosforo-carbono-nitrogenio
BR8103889A (pt) Processo para a preparacao de compostos
BR8000970A (pt) Processo para a preparacao de compostos de diorganomagnesio
BR8006222A (pt) Processo para a preparacao de esteres
BR8000626A (pt) Processo para a preparacao de uretanas
BR7905306A (pt) Processo para a preparacao de acidos arilglioxilicos
BR7902711A (pt) Processo para a preparacao de uretanas
BR8007962A (pt) Processo para a preparacao de compostos de benzazolila
BR7903638A (pt) Processo para a preparacao de compostos de tioindigo processo para a preparacao de compostos de tioindigo
BR8002993A (pt) Processo para a preparacao de poliorganossiloxanas poliramificadas
BR7903467A (pt) Processo para a preparacao de acidos arilglioxilicos
BR7903635A (pt) Processo para a preparacao de 2-oximinofenilacetonitrila processo para a preparacao de 2-oximinofenilacetonitrila
BR8004974A (pt) Processo para a preparacao de 4-fluor-3-fenoxi-tolueno
BR8101594A (pt) Processo para a preparacao de compostos de dihalogenotriazinil-amino-naftol
BR7907402A (pt) Processo para a preparacao de 3-fenoxi-benzaldeidos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911125

NF3A Restitutio in integrum

Effective date: 19930923

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010531

NF3A Restitutio in integrum

Free format text: RESTITUTIO IN INTEGRUM

Effective date: 20031120

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20061125